Mirdametinib CAS No.391210-10-9 Pharmaceutical Intermediates

Introducing Mirdametinib, a revolutionary compound designed to meet the evolving needs of the pharmaceutical industry. Our products have superior physical and chemical properties, making them the first choice for researchers and manufacturers. As a factory integrating production and trading, we ensure the highest quality standards and competitive prices. With Mirdametinib, you get reliable, effective and innovative solutions to enhance your drug formulations and research projects.

product details

Product details

Product detail

Mirdametinib, also known as PD-0325901, is a potent and selective inhibitor of MEK1 and MEK2 kinases, two kinases that play a crucial role in the MAPK signaling pathway. This pathway is frequently dysregulated in various cancers, making Mirdametinib a valuable asset in cancer research and treatment. Our products are synthesized using advanced manufacturing technologies to ensure high purity and consistency, which is critical for pharmaceutical applications.

product detail

CAS No.	40856-44-8
EINECS	609-874-3
Formula	C9H11NO2
Molecular Weight	165.19
Appearance	White to Off-White solid
Purity	≥98%
Type	Pharmaceutical Intermediates

Physical and Chemical Properties

Mirdametinib exhibits a range of favorable physical and chemical properties that enhance its usefulness in the pharmaceutical field:

- Molecular formula: C16H14F3IN2O4

- Molecular weight: 482.19 g/mol

- Appearance: Mirdametinib is usually a white powder that is easy to handle and formulate.

- Solubility: It is soluble in organic solvents such as DMSO and ethanol and can be widely used in pharmaceutical formulations.

- Stability: Mirdametinib exhibits excellent stability under standard storage conditions and is suitable for long-term use in pharmaceutical products.

These properties not only facilitate the formulation of effective therapeutic agents, but also ensure that Mirdametinib can be easily integrated into existing pharmaceutical processes.

Advantages

1. Targeted Action: Mirdametinib’s selective inhibition of MEK1 and MEK2 enables targeted treatment strategies, minimizing off-target effects and improving therapeutic efficacy.

2. Versatility: This compound can be used in a variety of applications, including combination therapies, making it a versatile tool for researchers and drug developers.

3. High Purity: Our rigorous manufacturing process ensures that Mirdametinib is of high purity, which is critical for both research and clinical applications.

4. Competitive Pricing: As a factory integrating production and trading, we offer Mirdametinib at competitive prices without compromising on quality, making it accessible to a wide range of customers.

5. Regulatory Compliance: We adhere to strict regulatory standards to ensure that Mirdametinib meets the necessary quality and safety requirements for pharmaceutical use.

Application

Mirdametinib is primarily being developed as a targeted cancer therapy. Its ability to inhibit the MEK pathway makes it a promising candidate for the treatment of various malignancies, including melanoma, colorectal cancer, and other solid tumors. Researchers are increasingly exploring its potential for combination with other therapeutic agents to enhance treatment efficacy and overcome resistance mechanisms.

In addition to oncology, mirdametinib is also being investigated in other therapeutic areas, including inflammatory diseases and neurodegenerative diseases. Its role in modulating cell signaling pathways opens new avenues for drug development and therapeutic intervention.

In summary

Mirdametinib is a top-tier product in the pharmaceutical industry, with a unique combination of targeted action, high purity, and versatility. Our commitment to quality and competitive pricing makes us a trusted partner for researchers and manufacturers. By choosing Mirdametinib, you invest in a product that not only meets but exceeds the demands of modern pharmaceutical applications. Contact us today to learn more about how Mirdametinib can enhance your research and development efforts.